Herman Moreno, MD

Affiliations: 
Pharmacology SUNY Downstate Medical Center, Brooklyn, NY, United States 
Area:
Alzheimer's Disease, Calcium Dynamics, Brain metabolism
Website:
http://www.downstate.edu/pharmacology/faculty/moreno.html
Google:
"Herman Moreno"
Mean distance: 13.16 (cluster 6)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Llinas R, Moreno H. (2017) Perspective on calcium and Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Gutiérrez-Vargas JA, Moreno H, Cardona-Gómez GP. (2016) Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Moreno H, Morfini G, Buitrago L, et al. (2016) Tau Pathology Mediated Presynaptic Dysfunction. Neuroscience
Barone FC, Gustafson D, Crystal HA, et al. (2016) First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia. Journal of Translational Medicine. 14: 50
Sandoval-Hernández AG, Buitrago L, Moreno H, et al. (2015) Role of Liver X Receptor in AD Pathophysiology. Plos One. 10: e0145467
Moreno H. (2015) It is not as simple as «I will put you to sleep»: A neurological perspective on sedation | No es tan sencillo como «Te pondré a dormir»: Una perspectiva neurobiológica sobre la sedación Revista Colombiana De Anestesiologia. 43: 173-175
Choi S, Yu E, Rabello G, et al. (2014) Enhanced synaptic transmission at the squid giant synapse by artificial seawater based on physically modified saline. Frontiers in Synaptic Neuroscience. 6: 2
Lewandowski NM, Bordelon Y, Brickman AM, et al. (2013) Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93
Lewandowski NM, Bordelon Y, Brickman AM, et al. (2013) Corrigendum to "Regional vulnerability in Huntington's disease: FMRI-guided molecular analysis in patients and a mouse model of disease" [Neurobiol Dis 52 (2013) 84-93] Neurobiology of Disease. 54: 115
Cepeda-Prado E, Popp S, Khan U, et al. (2012) R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6456-67
See more...